Clinical studies have convincingly demonstrated that significant expression of S100A4 in primary tumors is indicative of poor prognosis (16–18), and that S100A4 may be a useful marker for predicting the development, progression and metastasis of human gastric cancer (19). This evidence concerns the gene S100A4 and gastric cancer.